HIGHLIGHTS
GABAergic neurons are a direct target of thyroid hormone in the developing brain Impaired TH/TRa1 signaling severely impairs the development of GABAergic neurons GABAergic-specific genes directly targeted by TH/ TRa1 signaling have been listed A defect in the GABAergic system is expected in patients with a THRA mutation DATA AND CODE AVAILABILITY INTRODUCTION Thyroid hormones (TH, including thyroxine, or T4, and 3,3 0 ,5-triiodo-L-thyronine, or T3, its active metabolite) exert a broad influence on neurodevelopment. If untreated soon after birth, congenital hypothyroidism, i.e. early TH deficiency, affects brain development and a number of cognitive functions (Rovet, 2014) . Severe cases display mental retardation, autism spectrum disorders (ASD), and epilepsy (Fetene et al., 2017) . TH mainly acts by binding to nuclear receptors called TRa1, TRb1, and TRb2, which are encoded by the THRA and THRB genes (Thra and Thrb in mice, formerly TRa and TRb). These receptors form heterodimers with other nuclear receptors, the retinoid X receptors (RXRs), and bind chromatin at specific locations (thyroid hormone response elements), acting as TH-dependent transcription activators of neighboring genes. In the developing brain, the predominant type of receptor is TRa1 (Bradley et al., 1989) . Accordingly, THRA germline mutations, which have currently been reported in only 45 patients, cause a syndrome named RTHa (resistance to thyroid hormone due to THRA mutations), resembling congenital hypothyroidism, with mental retardation and a high occurrence of ASD and epilepsy (van Gucht et al., 2017) . Cellular alterations caused by early TH deficiency or germline mutations have been extensively studied in rodents. Many neurodevelopmental processes depend on proper TH signaling, and virtually all glial and neuronal cell populations are affected by TH deficiency (Berbel et al., 2014; Bernal et al., 2003) . However, in the mouse cerebellum, we have previously found that, although Thra expression is ubiquitous in this brain region, only a subset of cell types displayed a direct, cell-autonomous, response to TH (Fauquier et al., 2014) . More specifically, Cre/loxP technology, used to express a dominant-negative variant of TRa1 (TRa1 L400R ), has provided genetic evidence that the cell-autonomous influence of TRa1 is limited to astrocytes and GABAergic neurons (Fauquier et al., 2014) . By altering the differentiation of GABAergic neurons, TRa1 L400R prevented the secretion of several growth factors and neurotrophins. This indirectly altered the proliferation and differentiation of granule cells and oligodendrocytes (Picou et al., 2012 (Picou et al., , 2014 . Therefore, GABAergic neurons occupy a pivotal position during cerebellum development, amplifying the initial TH signal. This allows TH to synchronize cellular interactions and the maturation of neuronal networks during the first post-natal weeks (Flamant et al., 2017) . As defects in TH signaling are known to alter GABAergic neurons outside the cerebellum (Berbel et al., 1996; Harder et al., 2018; Wallis et al., 2008) , we asked whether the direct role of TH in GABAergic neurons, initially observed in the cerebellum, could be generalized to other brain regions.
In the present study, we used the same genetic strategy to block TH response in the entire GABAergic lineage by expressing TRa1 L400R from early developmental stages specifically in GABAergic neurons in all brain areas. This had dramatic neurodevelopmental consequences on the development of the GABAergic system and caused lethal epileptic seizures. Genome-wide analyses allowed us to pinpoint the genetic defects induced by the mutation and to identify a small set of genes activated by TH in GABAergic neurons. These genes are likely to play a key role in the neurodevelopmental function of TH.
RESULTS

Mouse Models Designed to Target TRa1 in GABAergic Neurons
We generated new mouse models by combining existing and novel ''floxed'' Thra alleles with the Gad2Cre transgene ( Figure 1A ). This transgene drives the expression of Cre recombinase in all GABAergic neurons and their progenitors from an early prenatal stage (around E12.5) . In the context of the modified Thra alleles used in the present study, Cre recombinase eliminates a transcriptional stop cassette and triggers the expression of TRa1 variants. The Thra AMI allele (formerly TRa AMI ) ( Figure 1 . Thra Alleles and Survival Curves (A) Schematic representation of Thra alleles in Thra AMI , Thra Slox and Thra TAG mice. In all 3 alleles, the coding sequence is preceded with a floxed stop cassette (PGKNeo Poly(A). The intronless structure eliminates alternate splicing and internal promoter and thus prevents the production of TRa2, TRDa1, and TRDa2 non-receptor protein. The dispensable IRES Tau-lacZ reporter part was not included in the Thra TAG construct. (B) C-terminal amino acid sequence of Thra gene products used in the present study, starting from AA393. Shaded amino acids differ from wild-type TRa1. Thra AMI mutation results in a single amino acid substitution within TRa1 helix 12. Thra Slox mutation is a deletion resulting in a +1 frameshift, leading to elimination of helix 12, as in several RTHa patients. (C) Survival curves of mice expressing a mutated TRa1 in GABAergic neurons (green and red lines) and of control littermates (black line). See also Figures S1-S3 and Videos S1 and S2. et al., 2007) encodes TRa1 L400R ( Figure 1B ), which exerts a permanent transcriptional repression on target genes, even in the presence of TH. This is due to its inability to recruit transcription coactivators, which normally interact with the C-terminal helix (AA 398-407) of TRa1, and permanent interaction with transcription corepressors ( Figure S1 ). This allelic design, which eliminates alternate splicing, increases the expression of the mutant receptor over that of the wild-type receptor, as shown by comparing peak surfaces after Sanger sequencing: in the striatum of Thra AMI/gn mice, the Thra AMI allele represents 65 G 4% of all Thra transcripts (mean G standard deviation, n = 4; see also ). This ensures a complete inhibition of TH response in heterozygous cells . As complete deprivation of TH (Mansouri et al., 1998) , ubiquitous expression of TRa1 L400R results in the death of heterozygous mice 2-3 weeks after birth . The second modified Thra allele, named Thra Slox , differs from Thra AMI only by an additional frameshift mutation, which eliminates the C-terminal helix of TRa1 . As for Thra AMI , expression of the Thra Slox allele exceeds that of the wild-type Thra allele: in the striatum of Thra Slox/gn mice, the Thra Slox allele represents 59 G 1% of all Thra transcripts (mean G standard deviation, n = 6). The Thra Slox allele encodes TRa1 E395fs401X ( Figure 1B) , which is nearly identical to a pathological variant found in a patient (van Mullem et al., 2012 (van Mullem et al., , 2014 . TRa1 E395fs401X is expected to be functionally equivalent to TRa1 L400R and behaves similarly in in vitro assays . The third modified Thra allele used in the present study is Thra TAG , a novel construct that encodes a functional receptor, TRa1 TAG , with a fragment of protein G at its N-terminus (Burckstummer et al., 2006) . This tag has a high affinity for IgGs, which makes it suitable to address chromatin occupancy (Chatonnet et al., 2013) . Transient expression assays show that the N-terminal GS tag does not impair the transactivation capacity of TRa1 ( Figure S2 ). Double heterozygous mice, combining the presence of GADad2Cre and of a modified Thra allele, express TRa1 L400R , TRa1 E395fs401X , or TRa1 TAG in the GABAergic cell lineage only. They will be respectively designated as Thra AMI/gn , Thra Slox/gn , and Thra TAG/gn in the following,/gn being used to indicate that the modified Thra alleles were expressed specifically in GABAergic neurons. In all phenotyping experiments, littermates carrying only Thra AMI , Thra Slox , or GAD2Cre were used as controls.
Post-natal Lethality Caused by Thra Mutations in GABAergic Neurons
Born at the expected frequency, Thra AMI/gn mice did not usually survive beyond the third post-natal week ( Figure 1C ). Video recording of litters in their home cage indicated that most mice started to display epileptic seizures a few days before death. Occasionally, sudden death was observed at the end of a seizure. In most cases, seizures impeded maternal care and this likely precipitated the death of the pups (Videos S1 and S2). Although lethality was also observed in Thra Slox/gn mice ( Figure 1C ), about one-third of these mice survived into adulthood. Adult Thra Slox/gn mice did not display any obvious epileptic seizure anymore. However, their locomotor behavior was significantly altered, as evidenced in an open-field test ( Figure S3 ). These observations show that, although the two mutations are expected to be equivalent, TRa1 E395fs401X is less detrimental than TRa1 L400R .
A Global Impairment in the Differentiation of GABAergic Neurons
In order to label neurons of the GABAergic lineage in a generic way, we combined the Thra AMI and Gad2-Cre alleles with the Rosa-tdTomato transgene, which enabled to trace the cells in which Cre/loxP recombination had taken place. The density of tdTomato + cells was not reduced in Thra AMI/gn Rosa-tdTomato mice, arguing against a possible alteration in the proliferation, migration, or survival of GABAergic neuron progenitors. In the hippocampus, notably in the dentate gyrus, the number of tdTomato + cells was even increased ( Figure 2 ).
We used immunohistochemistry to detect alterations of GABAergic neuron differentiation at postnatal day 14 (PND14) in various brain areas (quantitative data in Tables 1 and S1). Parvalbumin (PV) immunostaining, which labels major populations of GABAergic neurons in several brain areas (DeFelipe et al., 2013) , revealed a defect in Purkinje cell arborization and a deficit in basket and stellate GABAergic interneurons in Thra AMI/gn cerebellum as expected from previous data (Fauquier et al., 2011; ( Figure S4 ). A drastic reduction in the density of PV + neurons (90%-95% reduction relative to controls) was also visible in the hippocampus, cortex, and striatum of Thra AMI/gn mice ( Figure 3A ). As a complement to PV labeling, we used Wisteria floribunda lectin (WFA) to label perineuronal nets, as it has been previously reported that a reduction in PV + neuron numbers may be accompanied by a persistence of these extracellular matrix structures (Filice et al., 2016) . In Thra AMI/gn mice, WFA labeling was drastically reduced compared with that of control mice, but perineuronal nets were observed around PV-negative cell bodies ( Figure S5 ), suggesting that absence of PV labeling was not necessarily a sign of PV neuron loss. We also used antibodies directed against calretinin (CR), somatostatin (SST), and neuropeptide Y (NPY) to label other key populations of GABAergic neurons (Kepecs and Fishell, 2014) . All GABAergic neuron subtypes investigated were affected but in a rather complex pattern. The density of CR + neurons was increased in the cortex and CA2-CA3 area of the hippocampus. In the hippocampal dentate gyrus, where CR + neurons are normally concentrated in the granular cell layer, the limits of this layer were ill-defined and CR + neurons spread into the molecular and polymorph layers ( Figure 3B ). The density of SST + neurons was also augmented in hippocampal dentate gyrus but not significantly altered in the cortex or striatum ( Figure 4A ). The density of NPY + neurons was significantly reduced in the cortex, but not in the striatum and hippocampus, where, by contrast, NPY immunoreactivity of the fibers increased (Figures 4B and Table 1 ).
Most of the above-mentioned immunohistochemistry experiments were also carried out in Thra Slox/gn mice at PND14. In all instances, the defects observed in GABAergic neuron populations were the same as in Thra AMI/gn mice (details in Table S1 and Figure S6 ). In the surviving Thra Slox/gn adult mice, PV and NPY immunohistochemistry indicated that the differentiation of neurons expressing these markers was not only delayed, but permanently impaired ( Figure S7 and Table S1 ). Taken together, these data indicate that expressing a mutant TRa1 alters the late steps of development of GABAergic neurons, reducing the numbers of PV+ and NPY + cells in some brain areas, while favoring an expansion of the SST+ and CR + cell populations. In the hippocampus, this is accompanied by subtle morphological alterations.
Changes in Gene Expression Caused by TRa1 L400R in GABAergic Neurons
Because the impairment in GABAergic neuron differentiation does not appear to be restricted to a specific brain area or a specific neuronal GABAergic subpopulation, we hypothesized that a general (C) Relative density of tdTomato + cells in Thra AMI/gn Rosa-tdTomato (''M'' in the graph stands for mutants, filled triangles; red lines for the mean and standard deviation) and control littermates (''C'', empty circles; blue lines for the mean and standard deviation) at PND14. *p < 0.05. mechanism might underlie the involvement of TH signaling in the terminal maturation of GABAergic neurons. In order to decipher this mechanism and identify the TRa1 target genes in GABAergic neurons, we first compared the transcriptome of the cortex in Thra AMI/gn and control littermates at two different post-natal stages, PND7 and PND14, where we previously found clear histological alterations. Differential gene expression analysis pointed out a set of 58 genes whose expression was deregulated in Thra AMI/gn mouse cortex, compared with age-matched control mice. Clustering analysis outlined contrasting patterns of regulations ( Figure S8 ). Exploring available single-cell RNAseq data (https:// singlecell.broadinstitute.org) obtained from adult visual cortex (Tasic et al., 2016) suggests that a large part of the observed variations reflect the alterations in neuronal maturation already revealed by immunohistochemistry. For example, many downregulated genes are preferentially expressed in PV + neurons (Akr1c18, Dusp10, Eya4, Flywch2, Me3, Ntn4, Pcp4L1, Ppargc1a, Pvalb, Stac2, Syt2) whereas most overexpressed genes are preferentially expressed in SST+ and/or VIP + GABAergic interneurons (Calb1, Cxcl14, Hap1, Klhl14, Pcdh8, Prox1, Rbp4, Rxfp3, Sema3c, Sst, Tac2, Zcchc12). Interestingly, the analysis also revealed an upregulation of Thra at PND7 in control mice, which was absent in mutant mice. However, we expected a larger set of differentially expressed genes on the basis of previous in vitro analysis (Gil-Ibanez et al., 2014) . This probably results from the relatively low representation of GABAergic neurons among cortical cells. We thus decided to focus our investigation on the striatum, where the high abundance of GABAergic neurons, mainly spiny projection neurons, facilitates analysis. As expected, the same differential gene expression analysis identified a larger set of differentially expressed genes in the striatum (191 genes). A single factor Deseq2 analysis pointed out 126 genes whose expression was deregulated at PND7 in the striatum of Thra AMI/gn mice, compared with agematched control mice. At PND14, this number raised to 215 genes. Overall, 260 genes were found to be deregulated in the striatum of Thra AMI/gn mice at either stage. Eight of these genes (Cxcl14, Flywch2, Glra3, Ppargc1a, Prox1, Pvalb, Sst, Syt2) were also deregulated in the cortex. Hierarchical clustering analysis of the striatum data mainly revealed a sharp transition between PND7 and PND14 in the striatum of control mice, which did not take place in Thra AMI/gn mice ( Figure 5 ).
Cortex
Hippocampus ( Table S1 . a Significantly different from control (p < 0.05).
These differences in gene expression, as measured by Ampliseq, may have two origins. They can reflect deregulations of the expression of TRa1 target genes in GABAergic neurons, but they can also reflect various indirect consequences of these deregulations, such as a change in the composition of the cell population. In order to pinpoint the TRa1 target genes within the set of differentially expressed genes in striatum, we crossed the above results with a dataset obtained in wild-type mice, comparing different hormonal statuses. We assumed that the expression of TRa1 target genes should be quickly modified by changes in TH levels, whereas indirect consequences should be much slower. In the dataset, 181 genes were found to be deregulated in the striatum of hypothyroid mice, whereas 86 genes responded to a 2-day TH treatment of hypothyroid mice (Dataset S1). RT-qPCR was used to confirm some of these observations (Tables S2-S4 ). In this dataset, however, the response of GABAergic neurons to TH cannot be distinguished from the response of other cell types present in the striatum, which also express TRa1. The overlap between the two datasets pointed out a set of 38 TH-activated genes whose expression pattern suggested a direct regulation by TRa1 in GABAergic neurons, whereas only 1 gene displayed an expression pattern that suggests a negative regulation by T3-bound TRa1 ( Figure 6A ).
Identification of Direct TRa1 Target Genes in GABAergic Neurons of the Striatum
To complete the identification of TRa1 target genes in striatal GABAergic neurons, we analyzed chromatin occupancy by TRa1 at a genome-wide scale by ChIPseq. Using Thra TAG/gn mice, we precipitated the DNA/ protein complexes, which contain the tagged TRa1 from the whole striatum, to address chromatin occupancy in GABAergic neurons only. occupied by TRa1 TAG (thyroid hormone receptor binding sites = TRBSs) in the genome ( Figure 6B ). In agreement with our previous study (Chatonnet et al., 2013) de novo motif discovery (http://meme-suite. org/tools/meme-chip) and enrichment analysis revealed a single consensus sequence for the binding of TRa1/RXR heterodimers. The sequence is the so-called DR4 element ( Figure 6C ). Assuming that proximity (<30kb) between the TRa1 TAG binding site and the transcription start site is sufficient for direct transcriptional regulation by TRa1 would lead to consider a large fraction of genes as putative target genes (3,979/ 23,931 annotated genes in the mouse genome mm10 version; 16.6%). Among the 38 genes that are sensitive to TRa1 L400R expression and hypothyroidism and responsive to TH in hypothyroid mice, genes with a proximal TRBS were overrepresented (35/38: 92%; enrichment of 5.5 compared with the whole set of annotated genes). Interestingly, this enrichment was more striking if we considered only the TRBSs where a DR4 element was identified (3,813/7,484; 51%): DR4 elements were present within 30 kb of 7.5% of annotated genes (1,786/23,931) and of 45% of the putative TRa1 target genes identified in the present study (17/38) ( Figure 6D ). The same reasoning leads to the conclusion that the transcription of genes that are downregulated after T3 treatment is not regulated by chromatin-bound TRa1 ( Figure 6D ). Overall, the ChipSeq dataset suggests that a large fraction of the TRBS does not reflect the binding of TRa1/RXR heterodimers to DR4 elements but corresponds to other modes of chromatin association, which do not necessarily promote TH-mediated transactivation. However, as we cannot rule out that other types of response elements are also used, this analysis leaves us with 35 genes, which meet all the criteria for being considered as TRa1 direct target genes. Although some of these genes are known to have a neurodevelopmental function, they do not fall into a specific ontological category (Table S5 ). This implies that TH promotes GABAergic neuron maturation by simultaneously acting on different cell compartments and cellular pathways. 
DISCUSSION
Using two mouse models expressing mutant forms of TRa1 specifically in GABAergic neurons, we present evidence showing that TH, bound to TRa1, is required for the late steps of development of GABAergic neurons. As in the present study we have used GABAergic-specific somatic mutations, we can ascertain that the observed defects are cell-autonomous consequences of impaired TH signaling. We found that the defect in GABAergic differentiation is not restricted to a specific brain area, nor to a specific subtype of GABAergic neurons, as several subtypes of both projecting neurons and interneurons were affected by TRa1 mutations. This suggests that, although GABAergic neurons of different brain areas have different embryonal origins (Leto et al., 2006; Marin and Muller, 2014) , they share a common pathway of maturation that depends on TH/TRa1 signaling. Transcriptome analysis revealed a significant overlap between the regulated genes of mutant mice in the cortex, where most GABAergic neurons are interneurons, and in the striatum, which is mainly populated by projecting GABAergic neurons, i.e., medium spiny neurons.
These results extend previous findings, obtained either in hypothyroid rodents or in mice with Thra mutations, demonstrating the role of TH in GABAergic neurons in the cerebellum (Fauquier et al., 2011; Manzano et al., 2007) , striatum (Diez et al., 2008) , cortex (Wallis et al., 2008) , hippocampus (Navarro et al., 2015) , and hypothalamus (Harder et al., 2018) . The major contribution of the present work is to demonstrate that the effect of TH/TRa1 on GABAergic neuron development is cell-autonomous. In many respects, neurodevelopmental damage caused by TRa1 L400R and TRa1 E395fs401X appears to be similar to, but more dramatic than, that reported for the ubiquitous TRa1 R384C mutation (Wallis et al., 2008) , which is impaired in its affinity for TH, but possesses a residual capacity to transactivate gene expression (Tinnikov et al., 2002) . The effects reported here with Thra knock-in mutations are also congruent with, although much stronger than, those previously reported in the brains of Thra KO mice . This difference is not a surprise and has been previously shown to derive from the permanent transcriptional repression exerted by TRa1 L400R and TRa1 E395fs401X in presence or absence of TH (Flamant et al., Figure 5 . Differentially Expressed Genes in the Striatum Hierarchical clustering analysis of differentially expressed transcripts in the striatum of Thra AMI/gn mice and control littermates at PND7 and PND14. The analysis is restricted to 260 genes for which the fold-change is > 2 or <0.5 (adjusted p value < 0.05) for at least one developmental stage. High expression is in yellow, low expression is in blue, average in black. Note that the changes in gene expression between PND7 and PND14 are more conspicuous in control than in mutant mice, suggesting that a maturation process is blunted by the mutation. See also Figure S8 and Tables S2 and S4. 2017). The transcriptional repression effect exerted by unliganded TRa is completely lost in Thra KO mice, resulting in a much milder phenotype.
The present data indicate that TRa1 plays a major role in the late steps of development of several categories of GABAergic neurons. This is most obvious for PV + interneurons, which almost disappear from several brain areas in Thra AMI/gn mice. However, their progenitors appear to be present, as evidenced by the use of tdTomato as a reporter for cells of the GABAergic lineage. Thus, we can exclude that TRa1 plays a major role in the first steps of GABAergic neuron development, i.e., progenitor proliferation and migration.
In the hippocampus, the density of tdTomato+ and CR + cells was higher in Thra AMI/gn mice than in controls, and the limits of the granular layer were blurred. These results are congruent with previous studies. Indeed, blurring of the borders of the granular layers has been observed in hypothyroid rats (Navarro et al., 2015) . An increase in CR + cells has also been reported in the hippocampus of mice expressing TRa R384C (Hadjab-Lallemend et al., 2010) . Thus, we can speculate that TH signaling in GABAergic neurons plays a role in the process of lamination in the hippocampus. In particular, the increase in tdTomato + cells in the hippocampus of Thra AMI/gn mice may result from impaired cell apoptosis, possibly affecting CR neurons.
The fate of the progenitors that fail to express PV in Thra AMI/gn mice is unclear. One hypothesis is that they commit to a different GABAergic lineage. This could notably explain the excess of SST + cells in the hippocampus, because PV+ and SST + cortical interneurons share the same precursors (Hu et al., 2017; Mukhopadhyay et al., 2009 ). However, the results obtained in the cortex do not support such hypothesis, because the density of SST + cells in the cortex did not differ between Thra AMI/gn mice and their control littermates. An alternative hypothesis would be that the effects observed in different categories of GABAergic neurons are secondary to the near disappearance of PV + interneurons. Indeed, many defects caused by hypothyroidism in the brain are indirect, some of them being secondary to a defect in neurotrophin secretion in the microenvironment (Bernal, 2002; Giordano et al., 1992; Neveu and Arenas, 1996; Yu et al., 2015) .
Our genome-wide search pinpointed a small set of genes fulfilling the criteria, which lead us to consider them as genuine TRa1 target genes in GABAergic neurons: (1) the mRNA level of these genes is TH responsive, (2) it is decreased in the striatum of Thra AMI/gn mice, and (3) TRa1 occupies a chromatin binding site located at a limited distance of their transcription start site. The last criterion is important, as it helps to differentiate between direct and indirect influences of TRa1 on gene regulation. Thus, we have addressed chromatin occupancy by TRa1 in vivo, in the striatum. Importantly, we have used a genetic strategy enabling to selectively identify GABAergic neuron-specific TRa1 binding to DNA within a heterogeneous tissue. The large number of chromatin binding sites that we have identified (7,484 TRBS) contrasts with the small set of 35 genes that we have identified as being directly regulated by TRa1 in GABAergic neurons. As we have used stringent statistical thresholds, we have probably overlooked some genuine TRa1 genes. For example, Klf9 is a known target gene (Chatonnet et al., 2015) , which is not present in our list, due to a below-threshold downregulation in the striatum of hypothyroid mice. However, even with liberal statistical thresholds, the number of presumptive target genes would not exceed 100, a number which is still small compared with the number of genes with a proximal TRBS. Such a contrast has previously been observed in other systems (Ayers et al., 2014; Chatonnet et al., 2013; Grontved et al., 2015; Ramadoss et al., 2014) and suggests that only a small fraction of the TRBSs Figure 6 . Identifying a Core Set of TRa1 Target Genes in GABAergic Neurons of the Striatum by Combining RNAseq and Chip-Seq Analyses (A) RNAseq identifies a set of 38 genes, the expression pattern of which is fully consistent with a positive regulation by TRa1, and only 1 gene that has the opposite expression pattern. (B) Extract of the Mus musculus genome browser, around the Hr gene, a well-characterized TRa1 target gene. The 3 upper boxes indicate TRBSs identified as significant by the MACS2 algorithm. Note that a DR4-like element (lower track, red asterisks), as defined below, is found in only one of the 3 peaks. (C) Consensus sequence found in TRBSs identified by de novo motif search is close to the DR4 consensus (5 0 AGGTCANNNNAGGTCA-3 0 ). (D) Combinations of RNAseq and Chip-Seq data. In the Venn diagrams, each fraction gives the number of genes with a proximal TRBS (<30 kb for transcription start site, large lettering) and, among these genes, those in which a DR4 element was identified (small lettering). A set of 35 genes fulfill the criteria for being considered as genuine TRa1 target genes: they are downregulated in hypothyroid and mutant mice and upregulated after TH treatment of hypothyroid mice. For 17 of these genes, the TRBS contains a recognizable DR4-like element. See also Data S1 and Tables S2-S5. are involved in TH-mediated transactivation. Finally, the low level of correspondence between TRBSs and genes that are downregulated after T3 treatment ( Figure 6D ) suggests that the negative regulation of gene expression exerted by TH is not directly mediated by chromatin-bound TRa1, but perhaps an indirect consequence of the upregulation of transcription inhibitors. Further investigations will be required to better define these active TRBSs and better establish the correspondence between chromatin occupancy and transcriptional regulation by TRa1.
Most of the TRa1 target genes identified in the striatum have already been identified as being sensitive to the local TH level in various brain areas and at different developmental stages (see Table S1 in Chatonnet et al., 2015) . This reinforces the hypothesis that they belong to a common genetic program that is regulated by TH, via TRa1, and that promotes the proper maturation of several categories of GABAergic neurons. Although their function in neurons is for a large part unknown, these genes can be grouped according to the putative function of their protein products: Shh and Fgf16 encode secreted proteins, which play major roles in cellular interactions. Sema7a and Nrtn are involved in axon growth and pathfinding. Others are likely to define the electrophysiological properties of neurons by encoding ion channels (Kctd17), transporters of small metabolites (Slc22a3, Slc26a10), or modulators of synaptic activity (Nrgn, Lynx1).
Overall, the broad influence of TRa1 mutations on GABAergic neuron differentiation and maturation is expected to greatly and permanently impair brain function, notably in the cortex, where a subtle equilibrium between different GABAergic neuron subtypes is necessary for normal development and plasticity (Butt et al., 2017) . In the mouse models presented here, epileptic seizures appear to be a main cause of mortality, which sheds light on the cause of the lethality that had been previously observed in mice with different Thra mutations (Fraichard et al., 1997; Kaneshige et al., 2001; Tinnikov et al., 2002) as well as in mice suffering from complete TH deprivation (Flamant et al., 2002; Mansouri et al., 1998) . Of note, the increase in NPY intensity that we have reported in the striatum and hippocampus of mutant mice may be secondary to the occurrence of epileptic seizures in these mice. Indeed, epileptic seizures are known to increase the expression of NPY in various brain regions, including the hippocampus (Husum et al., 2002; Vezzani and Sperk, 2004) . The epileptic phenotype induced in mice by expressing a Thra mutation in GABAergic neurons is highly relevant to human pathology, as a history of epilepsy has been reported for several of the rare patients with a THRA mutation (Moran and Chatterjee, 2016) . Autism spectrum disorders (ASD), whose comorbidity with epilepsy is well documented, have also been reported in these patients (Kalikiri et al., 2017; Yuen et al., 2015) . It is likely that these pathological traits are also due to a defect in GABAergic neuron maturation, and our data suggest that these patients might benefit from a treatment with GABA receptor agonists.
Limitations of the Study
The modified Thra alleles used in the present study (Thra AMI , Thra Slox and Thra TAG ) result from an extensive remodeling of the Thra gene, which eliminates all the Thra-encoded proteins except for the mutated receptor. We have shown previously that such elimination of alternate splicing from the Thra locus resulted in a moderate overexpression of the mutant allele, compared with the wild-type allele. This overexpression is likely to lead to exaggerated phenotypic manifestations . Such exaggerated phenotype has proved efficient in bringing to light key mechanisms by which TH/TRa1 signaling impacts brain development, but the clinical relevance of these mouse models is questionable. Importantly, a similar, albeit milder phenotype has been evidenced in GABAergic neurons of CRISPR/Cas9-generated mice with Thra mutations, which are more relevant models of the human RTHa disease . Moreover, the epileptic phenotype observed in Thra AMI/gn and Thra Slox/gn mice appears to be congruent with the high occurrence of epilepsy, which has been reported in patients with RTHa (Moran and Chatterjee, 2015; van Gucht et al., 2017) . Thus, the mouse models used in the present study appear as relevant for the study of the mechanisms of TH/TRa1 during brain development, even though they do not faithfully mimic the human disease.
A second limitation lies in the use of TRBSs as indicators of direct TRa1 target genes. The conventional strategy, which only takes into account the distance between a TRBS and the nearest transcription start site, has limited value, as nuclear receptors sometimes act at very long distances due to chromosomal looping (Bagamasbad et al., 2008; Buisine et al., 2015 Buisine et al., , 2018 Further investigations will be required to better define the correspondence between chromatin occupancy by TRa1 and transcriptional regulation.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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Transparent methods
References for supplemental information Figure S1 . Related to Fig. 1 . TRα1 L400R ligand binding domain interacts with the NcoR transcription repressor even in the presence of T3. A. HEK293 cells, which do not express TRα1, were transfected with 3 plasmids: 1) a construct to drive the expression of a Gal4NcoR fusion protein. 2) A UASLuc construct with binding sites for the Gal4 DNA binding domain. 3) an expression vector to drive the expression of either the VP16-TRα1 or VP16-TRα1 L400R fusion. In absence of T3, the interaction between the TRα1 ligand binding domain and NcoR tethers the VP16 activation domain to the UASLuc promoter, resulting in luciferase expression. B. T3 addition destabilizes the interaction between TRα1 and NCoR, resulting in decreased luciferase activity. As it is unable to recruit transcription coactivators upon ligand binding, TRα1 L400R interacts with NcoR even in the presence of T3. Figure S2 . Related to Fig. 1 . A N-terminal GS tag does not impair the transactivation capacity of TRα1. HEK293 cells, which do not express TRα1, were transfected with a DR4-driven reporter plasmid construct with the luciferase coding sequence (TREluc) and a SV40-derived vector (pSG5) to drive either TRα1 or GS-TRα1 expression. Cells were then incubated in either control medium (-T3), or T3-supplemented medium (+T3, 10 -7 M). Luciferase activity was measured 48 hours after transfection. Each transfection was carried out in triplicate. Fig. 3 . The cerebellum of PND14 Thra AMI/gn exhibits typical hallmarks of hypothyroidism. Fluorescence microscopy images of the cerebellum of PND14 Thra AMI/gn and control mouse pups. Green fluorescence labels parvalbumin. Blue fluorescence labels cell nuclei (DAPI labelling). The reduced thickness of the molecular layer (ML) in Thra AMI/gn mice, compared to control mice, is related to a reduced arborization of Pukinje cell (PC) dendrites. By contrast, the external granular layer (EGL) is thicker in Thra AMI/gn mice than in control mice, which reflects a delay in the migration of granule cells towards the internal granular layer of the cerebellum. Table S3 . Related to Fig.6 and Dataset S1. Q-RT-PCR confirmation of the effect of hypothyroidism and TH stimulation on gene expression in the striatum of PND21 mouse pups. Data (mean ± standard deviation) are expressed as a fraction of the gene expression level in euthyroid mice. For each gene, p < 0.05 was found when comparing hypothyroid vs euthyroid mice, as well as when comparing hypothyroid+TH vs hypothyroid mice.
Gene
Euthyroid Hypothyroid Hypothyroid+TH Ace Whenever the influence of the age of the animals on the observed parameters was analyzed, we did not find any significant difference between males and females, which is congruent with the current literature on the role of thyroid hormone in mouse brain development. We indeed confirmed the absence of interaction between sex and thyroid hormone signaling at the genome-wide scale in our RNAseq analysis: differential gene expression analysis showed no effect of sex, except for 3 genes which are on the Y chromosome and thus expressed at low levels only in males. As our experiments were carried out using all mice from each litter, there was no bias in the sex of the animals: approximately half of them were males and half of them were females, but the male:female ratio in a given experiment was not necessarily harmonized between groups, since the sex was not considered as an influent parameter.
In order to target the expression of mutated forms of TRα1 specifically in GABAergic neurons, we used the Cre/loxP system with Gad2Cre mice (IMSR Cat# JAX:010802, RRID: IMSR_JAX:010802), which carry a Cre coding cassette immediately after the translation stop codon of the Gad2 gene. In Gad2Cre mice, Cre recombinase expression is almost entirely restricted to GABAergic neurons and includes almost all GABAergic neurons . Gad2Cre mice were crossed with Thra AMI/+ or Thra Slox/+ mice, which carry mutated versions of the Thra gene preceded with a floxed STOP cassette (Fig. 1) . When indicated, a Rosa26tdTomato reporter transgene (also known as Ai9, MGI Cat# 4436851, RRID: MGI:4436851) was also included (Madisen et al., 2010) . Finally, in order to address chromatin occupancy by TRα1 specifically in GABAergic neurons, we generated ad hoc Thra TAG/gn transgenic mice, which express a "tagged" receptor, TRα1 TAG , only in GABAergic neurons (Fig. 1) .
In order to compare the expression levels of mutant and wild-type Thra alleles, we evaluated peak surfaces after Sanger sequencing, using ICE software for quantification (Synthego, https://www.synthego.com/products/bioinformatics/crispr-analysis, see also :
https://www.biorxiv.org/content/10.1101/251082v1) and genomic DNA for calibration.
In order to compare animals with different thyroid statuses, TH deficiency was induced in pups by giving a diet containing propylthiouracil (TD95125; Harlan Teklad) to dams from post-natal day 0 (PND0) to post-natal day 21 (PND 21). In half of hypothyroid pups, TH levels were restored by two intraperitoneal injections of a mixture of T4 (2g/kg) and T3 (0.2g/kg) given at PND19 and PND20.
Brain collection
For neuroanatomy experiments, each mouse was given a lethal intraperitoneal injection (6 mL/kg) of a mixture of ketamine (33 mg/mL) and xylazine (6.7 mg/mL). The thorax was opened and each mouse was perfused with 4% paraformaldehyde in 0.1M phosphate buffer at room temperature.
Each brain was dissected out, immersed in fixative at 4°C for 3 hours and then in phosphate buffered saline (PBS) at 4°C until sectioning. Coronal sections (50 μm) were cut with the aid of a vibrating microtome (Integraslice 7550 SPDS, Campden Instruments, Loughborough, UK), in PBS at room temperature. Brain sections were stored at -20°C in cryoprotectant (30% ethylene glycol and 20% glycerol in 10 mM PBS) prior to immunohistochemistry. For transcriptome analyses, pups were killed by decapitation. The striatum was dissected out, snap frozen in either dry ice or liquid nitrogen and stored at -80°C prior to analysis. For Chip-Seq experiments, the 30kb upstream or downstream of the transcription start site to attribute a TRBS to a gene.
Although arbitrary, this distance was found to maximize the ratio of T3-responsive genes among the included genes, without excluding genes which have been well characterized as TRα1 target genes in other neural systems, such as Klf9 or Hr (Gil-Ibanez et al., 2015) .
q-RT-PCR
Striatum samples from 2-week old mice of either sex were dissected out, snap frozen and kept at −80•C until RNA extraction. Total RNA was extracted using RNeasy Mini kit (Qiagen). RNA concentrations were measured with a Nanodrop spectrophotometer (ThermoScientific) and 1 µg of each RNA sample was reverse transcribed in murine leukemia virus reverse transcriptase (Promega) and random DNA hexamer primers. Quantitative PCR was performed according to a standard protocol, using the Biorad iQ SYBRGreen kit and the Biorad CFX96thermocycler. Hprt, a housekeeping gene, was used as internal control. For each pair of primers (Table S4 ), a standard curve was established and PCR efficiency was controlled to be within usable range (90%-110%) before analysis using the 2 −DΔ(Ct) method (Livak and Schmittgen, 2001) .
Statistical analysis
The density of immunoreactive neurons, the intensity of immunofluorescence and the expression level of genes (qPCR data) of mutant mice were systematically analyzed as a fraction of the corresponding values observed in control littermates. Group means were subsequently compared between mutant and control mice using unpaired t-tests.
Data and software availability
RNASeq and ChipSeq data are accessible through GEO Series accession number GSE143933 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE143933).
